A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a ...

The CMS has just announced a new list of medicines selected for this program that includes Novo Nordisk's Wegovy, Ozempic, ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

Novo Nordisk’s connected insulin pens will integrate with the Abbott Freestyle Libre system, allowing Freestyle Libre users to see data about their insulin alongside their glucose readings, the ...

An Indian court has allowed Dr. Reddy’s Laboratories Ltd. to manufacture and export generic versions of Novo Nordisk A/S’s ...

Novo Nordisk has voluntarily recalled insulin cartridge holders used in six NovoPen Echo batches because they may crack or break if exposed to certain chemicals, like certain cleaning agents. Using a ...

And one of them is pharmaceutical giant Pfizer (NYSE: PFE). Now, with a major step along the path to entering this ...

This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected ...

NVO seeks an expedited FDA review for a higher 7.2 mg dose of Wegovy after strong weight-loss results in its STEP UP study.

PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare ...

Ozempic, a once-weekly injectable approved by the US Food and Drug Administration in 2017 for type 2 diabetes, has become a ...